Inhibitor Therapeutics, Inc. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d2779dd0-049c-4395-950b-45f5a852a596/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001193125-22-088832 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-095516 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001193125-21-095516 |
| FY 2018 | $0 | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-066503 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-047834 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-048025 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-446037 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-050220 |
| FY 2013 | $0 | 2013-01-01 – 2013-12-31 | evidence 0001193125-15-050220 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Inhibitor Therapeutics, Inc. — all facts · Net Income · Operating Income